- Category
- Micro (2020-21)
- Udyam number
- UDYAM-DL-04-0003555

Denovis Pharmaceuticals Private Limited
About Denovis Pharmaceuticals Private Limited
Data last updated:
Denovis Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 27 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2020PTC373804. Its GSTIN is 10AAICD1633M1ZW (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Aditya Bhardwaj and Kiran Prasad Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No – 17 Gali No – 08 Block – A – 2 West Sant Nagar Burari, Delhi, India – 110084.
As per the financials filed for FY 2024, the company reported a revenue of ₹82.34 Lakh, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹5.29 Lakh (net margin 6.4%) and EBITDA of ₹5.66 Lakh (EBITDA margin 6.9%).
The company has about 8 employees on its provident fund (EPFO) records.
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Denovis Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-04-0003555).
Company details
Recognitions & Rankings of Denovis Pharmaceuticals
Contact details
Denovis Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No – 17 Gali No – 08 Block – A – 2 West Sant Nagar Burari, Delhi, India – 110084
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
To see the full contact details of Denovis Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Denovis Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Denovis Pharmaceuticals Private Limited, buy the company report.
Financials of Denovis Pharmaceuticals Private Limited
FY 2025 filings availableDenovis Pharmaceuticals Private Limited reported revenue of ₹82.34 Lakh (up 37% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 37% in the latest year. EBITDA rose 207% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹5.66 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹5.29 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 6.9% | |||
| Net Profit Margin | 6.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Denovis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Denovis Pharmaceuticals Private Limited
Denovis Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aditya Bhardwaj | Director | 18 Feb 2023 | 3 Years 8 Months | Current |
| Kiran Prasad Singh | Director | 27 Nov 2020 | 5 Years 11 Months | Current |
| Krishna Mohan Prasad Singh | Director | 27 Nov 2020 | 5 Years 11 Months | Current |
Legal cases
Denovis Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (COMIP) | Filed against the company by Alkem Laboratories Ltd | Pending |
To see the full case history of Denovis Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Denovis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Denovis Pharmaceuticals Private Limited has a workforce of 8 employees on its EPFO records as of Jul 2025, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2025-26 | 8 |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Denovis Pharmaceuticals Private Limited, buy the company report.
GST
Denovis Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAICD1633M1ZW | Bihar | Active | 27 Apr 2021 |
To see the full GST registrations and return filing status of Denovis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Denovis Pharmaceuticals Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Aditya Bhardwaj was appointed as Director on 18 Feb 2023.
Frequently asked questions
Denovis Pharmaceuticals is an active private limited company based in Delhi, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 27 November 2020 (6+ years old) and is registered under CIN U24304DL2020PTC373804.
Denovis Pharmaceuticals has 3 current directors:
- Aditya Bhardwaj - Director
- Kiran Prasad Singh - Director
- Krishna Mohan Prasad Singh - Director
The latest financial statements of Denovis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Denovis Pharmaceuticals is 10AAICD1633M1ZW, registered in Bihar.
The CIN (Corporate Identification Number) of Denovis Pharmaceuticals is U24304DL2020PTC373804. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Denovis Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
Denovis Pharmaceuticals was incorporated on 27 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Aditya Bhardwaj was appointed as Director on 18 Feb 2023. Kiran Prasad Singh was appointed as Director on 27 Nov 2020. Krishna Mohan Prasad Singh was appointed as Director on 27 Nov 2020.
Yes, Denovis Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-04-0003555).
The registered office of Denovis Pharmaceuticals is at House No – 17 Gali No – 08 Block – A – 2 West Sant Nagar Burari, Delhi, India – 110084.

